The global Morphine Market, valued at USD 24.48 billion in 2022, is projected to reach USD 45.31 billion by 2030, exhibiting a robust compound annual growth rate (CAGR) of 8% during the forecast period from 2023 to 2030.Market DynamicsMorphine, a potent opioid analgesic, is widely used for the management of moderate to severe pain. The market growth is driven by the increasing prevalence of chronic pain conditions, rising incidences of cancer-related pain, and expanding geriatric population globally. Additionally, the growing accepta...
more